NCT05050448View on ClinicalTrials.gov

Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 31, 2022

Conditions
Knee Osteoarthritis
Interventions
DEVICE

Sustained Acoustic Device with 2.5% Diclofenac Patch

Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm@ with 2.5% Diclofenac patches.

DRUG

1% Diclofenac Topical Gel

Topical pain-relief gel

Trial Locations (3)

13053

Cayuga Medical Center - Medical Pain Consultants, Dryden

06905

Orthopaedic Foundation, Stamford

06611

ZetrOZ Systems, Trumbull

All Listed Sponsors
lead

ZetrOZ, Inc.

INDUSTRY

NCT05050448 - Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain | Biotech Hunter | Biotech Hunter